<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08034135273901</udiDi>
    <basicUdiDi>803413527TD066HYPRTNCPHU7</basicUdiDi>
    <tradeName>Edenight</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO073</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:35.634Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135273925</udiDi>
    <basicUdiDi>803413527TD066HYPRTNCPHU7</basicUdiDi>
    <tradeName>Edenight</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO072</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:35.614Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135273987</udiDi>
    <basicUdiDi>803413527TD067STNCPHTHLSC</basicUdiDi>
    <tradeName>Korneaker</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO059</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:35.603Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135274182</udiDi>
    <basicUdiDi>803413527TD067STNCPHTHLSC</basicUdiDi>
    <tradeName>Puro Protect</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO063</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:35.593Z</lastUpdated>
  </row>
  <row>
    <udiDi>08034135274199</udiDi>
    <basicUdiDi>803413527TD066HYPRTNCPHU7</basicUdiDi>
    <tradeName>Edenight</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NTC Srl</manufacturerName>
    <manufacturerSrn>IT-MF-000026977</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>HAO07</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T04:50:35.580Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057018170791</udiDi>
    <basicUdiDi>805701817S10VA4</basicUdiDi>
    <tradeName>Viscorib Plus 1.0</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IROMED GROUP S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000031267</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S10V004V</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T03:52:35.120Z</lastUpdated>
  </row>
  <row>
    <udiDi>08057018170807</udiDi>
    <basicUdiDi>805701817S15VAK</basicUdiDi>
    <tradeName>Viscorib Plus 1.5</tradeName>
    <deviceName></deviceName>
    <manufacturerName>IROMED GROUP S.R.L.</manufacturerName>
    <manufacturerSrn>IT-MF-000031267</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIa</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>S15V003V</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-16T03:52:35.101Z</lastUpdated>
  </row>
  <row>
    <udiDi>14260595530518</udiDi>
    <basicUdiDi>426059553MP19OSD012U</basicUdiDi>
    <tradeName>SiccaGel®</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Penta Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000006565</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>41118700</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-06-15T21:51:52.378Z</lastUpdated>
  </row>
  <row>
    <udiDi>04031626001924</udiDi>
    <basicUdiDi>4031626101888PR</basicUdiDi>
    <tradeName>VitA-POS</tradeName>
    <deviceName></deviceName>
    <manufacturerName>URSAPHARM Arzneimittel GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007748</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>MDR 2017/745</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-31T05:38:03.482Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311906942</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>Pe-Ha-Luron F 1.0%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-29T20:10:27.593Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311909189</udiDi>
    <basicUdiDi>42503119SOHY-F-OPHTHA7K</basicUdiDi>
    <tradeName>i-Visc 1.6%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030301</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, HYALURONIC ACID AND DERIVATIVES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-28T22:24:27.579Z</lastUpdated>
  </row>
  <row>
    <udiDi>04250311911694</udiDi>
    <basicUdiDi>42503119HPMC-OPHTHA4U</basicUdiDi>
    <tradeName>EasyVisc 2.4%</tradeName>
    <deviceName></deviceName>
    <manufacturerName>Albomed GmbH</manufacturerName>
    <manufacturerSrn>DE-MF-000007875</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf IIb</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>Q02030399</emdnCode>
    <emdnDescription>OPHTHALMOLOGY, VISCOELASTIC FLUIDS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference></reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-05-28T22:24:27.227Z</lastUpdated>
  </row>
</eudamedExport>